Interestingly, TRIM28 promotes drug resistance in GC cells by influencing Wnt/β-catenin signaling, indicating that TRIM28 is a promising drug target and potential prognostic factor (Ning et al., 2023). Here, TRIM28 is linked to gastric cancer.